DMT1 Protein

DMT1 Protein

Overview

Dmt1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

...

DMT1 Protein

Overview

Dmt1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Divalent Metal Transporter 1</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Divalent Metal Transporter 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[SLC11A2](/genes/slc11a2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8IWU6](https://www.uniprot.org/uniprot/Q8IWU6)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>NRAMP (Natural Resistance-Associated Macrophage Protein) family</td></tr>
<tr><td><strong> Molecular Weight</strong></td><td>~65 kDa (561 amino acids)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Endosomal membrane, Plasma membrane, Lysosomal membrane</td></tr>
<tr><td><strong>Top Brain Expression</strong></td><td>Substantia nigra, [Hippocampus](/brain-regions/hippocampus), Cerebral [cortex](/brain-regions/cortex)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">78 edges</a></td>
</tr>
</table>
</div>

Introduction

Divalent Metal Transporter 1 (DMT1), also known as SLC11A2 or NRAMP2, is a critical membrane protein responsible for the transport of ferrous iron (Fe²⁺) and other divalent metal ions across cellular membranes. DMT1 plays a fundamental role in systemic iron homeostasis by mediating dietary iron absorption in the duodenum and facilitating iron transport across the [blood-brain barrier](/entities/blood-brain-barrier) (BBB)[@gunshin1997][@fleming1997]. Dysregulation of DMT1 function has been strongly implicated in the pathogenesis of several neurodegenerative disorders, particularly Parkinson's disease (PD) and Alzheimer's disease (AD), where iron accumulation in specific brain regions is a hallmark feature[@salazar2008].

The protein belongs to the NRAMP family of divalent metal transporters, which are conserved from bacteria to humans and function as proton-coupled metal ion symporters[@klausner1995]. Understanding DMT1's role in neuronal iron homeostasis is crucial for developing therapeutic strategies targeting metal dysregulation in neurodegeneration.

Structure

DMT1 is a polytopic membrane protein with 12 predicted transmembrane domains that form a channel for metal ion transport. The protein contains:

• N-terminal extracellular/domain: Contains glycosylation sites important for protein folding and trafficking
• Transmembrane domain: Forms the ion channel pore, with conserved residues critical for metal binding and transport
• Transport mechanism: Operates as a proton-coupled symporter, using the proton gradient to drive iron import against concentration gradients
• Post-translational modifications: N-glycosylation at extracellular loops affects trafficking to the plasma membrane and endosomes

The crystal structure of bacterial NRAMP homologs has provided insights into the transport mechanism, revealing a flexible "bucket-handle" model where metal ions are transported through a channel formed by transmembrane helices[@structure2017].

Normal Function

Iron Absorption in the Intestine

In the duodenum, DMT1 is expressed on the apical membrane of enterocytes where it absorbs dietary non-heme iron (Fe²⁺). After reduction by duodenal cytochrome B (DCYTB), Fe²⁺ is transported into the enterocyte by DMT1. This absorbed iron is either stored as ferritin or exported into the bloodstream by ferroportin (FPN), where it is oxidized to Fe³⁺ and bound to transferrin[@gunshin1997][@fleming1997].

Iron Transport Across the Blood-Brain Barrier

DMT1 is expressed on the luminal side of brain capillary endothelial cells that form the BBB. Here, it mediates the uptake of transferrin-bound iron from the bloodstream into the brain. This process involves receptor-mediated endocytosis of transferrin, followed by iron release in the endosome via acidification, and finally DMT1-mediated iron export from the endosome into the cytosol and across the BBB[@moos2007].

Cellular Iron Homeostasis

Within [neurons](/entities/neurons) and glia, DMT1 localizes to endosomes and lysosomes, facilitating iron release from these organelles. This function is critical for delivering iron to the cytosol where it is used for:

• Mitochondrial iron-sulfur cluster biosynthesis
• Heme synthesis
• Iron-sulfur cluster-containing enzymes
• DNA synthesis in proliferating neural progenitor cells

Role in Neurodegeneration

Parkinson's Disease

DMT1 dysregulation plays a significant role in Parkinson's disease pathogenesis:

• Iron accumulation in substantia nigra: Multiple studies have shown increased DMT1 expression in the substantia nigra pars compacta (SNc) of PD patients, contributing to pathological iron deposition[@salazar2008][@wang2016]
• MPP⁺ toxicity: The Parkinsonian toxin MPP⁺ (1-methyl-4-phenylpyridinium) is imported by DMT1, the linking transporter to selective dopaminergic neuron vulnerability
• Mutations: The slc11a2 knockout mouse shows resistance to MPTP-induced parkinsonism, confirming DMT1's role in toxin uptake[@narskike2008]

Alzheimer's Disease

In Alzheimer's disease, DMT1 contributes to amyloidogenesis through iron-mediated processes:

• [Amyloid precursor protein](/entities/app-protein) processing: Iron regulates APP expression and processing via iron-responsive elements (IREs) in the APP mRNA
• [Tau](/proteins/tau) pathology: Iron accumulation activates kinases that phosphorylate tau, promoting neurofibrillary tangle formation
• Blood-brain barrier dysfunction: DMT1 overexpression in BBB endothelial cells may contribute to iron dysregulation in AD brain[@zheng2009]

Other Neurodegenerative Disorders

• Restless Leg Syndrome (RLS): DMT1 mutations are associated with RLS, a neurological disorder characterized by iron deficiency in the brain
• Aging: Normal aging is associated with increased brain iron, partly due to altered DMT1 expression
• Friedreich's ataxia: DMT1 dysregulation contributes to mitochondrial iron overload

Therapeutic Targeting

Small Molecule Inhibitors

• Erythropoietin: Has been shown to downregulate DMT1 expression and reduce iron-mediated neurotoxicity
• Deferoxamine: Iron chelator that can cross the BBB and reduce iron-induced oxidative stress
• Clioquinol: Metal-protein-attenuating compound that modulates DMT1 function[@kaur2014]

Gene Therapy Approaches

• RNAi-mediated knockdown: Targeting DMT1 expression to reduce pathological iron accumulation
• CRISPR-based editing: Potential to correct disease-causing mutations in SLC11A2

Neuroprotective Strategies

• Antioxidant therapy: Targeting iron-induced oxidative stress downstream of DMT1
• Iron chelation: Selective brain-targeted chelators (e.g., deferasirox, deferiprone)
• Modulation of upstream regulators: Targeting iron regulatory proteins (IRP/IRE system)

See Also

• [SLC11A2 Gene](/genes/slc11a2) — The gene encoding DMT1
• [Iron Homeostasis](/mechanisms/iron-homeostasis) — Overview of brain iron metabolism
• [Metal Metabolism](/mechanisms/metal-metabolism) — Metal ion transport in the brain
• [Parkinson's Disease](/diseases/parkinsons-disease) — PD and iron dysregulation
• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD and metal homeostasis
• [Neuroinflammation in AD](/mechanisms/microglia-neuroinflammation) — Iron and inflammation

Overview

Dmt1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Dmt1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Gunshin et al., Cloning and characterization of a mammalian proton-coupled metal-ion transporter (1997) (1997)](https://doi.org/10.1038/38702)

[Fleming et al., A mouse model of autosomal recessive iron overload (1997) (1997)](https://doi.org/10.1073/pnas.94.24.13181)

[Salazar et al., Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease (2008) (2008)](https://doi.org/10.1073/pnas.0800688105)

[Klausner et al., The NRAMP family of metal-ion transporters (1995) (1995)](https://doi.org/10.1016/S0968-0004(00)

[Unknown, Lu & Fu, Structure of the divalent metal transporter 1 in outward-open state (2017) (2017)](https://doi.org/10.1038/nature14393)

[Moos et al., DMT1 expression at the blood-brain barrier (2007) (2007)](https://doi.org/10.1007/s00401-006-0145-x)

[Wang et al., Increased DMT1 expression in Parkinson's disease substantia nigra (2016) (2016)](https://doi.org/10.3233/JPD-160842)

[Narskike et al., DMT1 knockout mice are resistant to MPTP neurotoxicity (2008) (2008)](https://doi.org/10.1523/JNEUROSCI.2928-08.2008)

[Zheng et al., DMT1 and iron homeostasis in Alzheimer's disease (2009) (2009)](https://doi.org/10.1016/j.neurobiolaging.2008.03.012)

[Kaur et al., Clioquinol attenuates iron-mediated neurotoxicity (2014) (2014)](https://doi.org/10.1007/s12031-014-0333-4)